Yes, lisinopril and aspirin can be taken together, but the FDA classifies this combination as a major interaction that requires careful monitoring. The primary concern is deterioration of kidney function, especially in elderly patients, those who are volume-depleted, or people with existing kidney disease. Aspirin can attenuate (reduce) lisinopril's blood pressure-lowering effect, meaning your medication may work less effectively than intended.
According to FDA drug labeling data, the lisinopril-aspirin interaction carries major severity status. The official safety concern states: "May result in deterioration of renal function including possible acute renal failure, especially in elderly or volume-depleted patients. Attenuates antihypertensive effect. Monitor renal function periodically."
This classification reflects real-world clinical concerns documented across multiple FDA adverse event reports. The combination appears frequently in older adults—populations most likely to be taking both medications for cardiovascular protection—making this a common clinical encounter in primary care, cardiology, and internal medicine practices.
The FDA's emphasis on "periodic" monitoring of renal function is not casual language. It signals that clinicians should establish a baseline creatinine and estimated glomerular filtration rate (eGFR) before combining these drugs, then check kidney function at regular intervals, particularly during the first weeks of combined therapy and whenever doses change.
Understanding why lisinopril and aspirin interact requires understanding how each drug affects blood flow and kidney function.
Lisinopril's mechanism: Lisinopril is an ACE (angiotensin-converting enzyme) inhibitor. It blocks the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, lisinopril dilates blood vessels (especially efferent arterioles in the kidney) and lowers blood pressure. Critically, this dilation of kidney blood vessels helps maintain glomerular filtration rate (GFR)—the kidney's ability to filter waste.
Aspirin's mechanism on kidney function: Aspirin inhibits cyclooxygenase (COX) enzymes, which produce prostaglandins. Prostaglandins, particularly PGE2 and PGI2, normally help dilate kidney blood vessels and maintain adequate blood flow to the glomerulus. When aspirin blocks prostaglandin synthesis, it causes vasoconstriction in the kidney—the opposite of what lisinopril does.
The collision: When lisinopril dilates efferent arterioles while aspirin simultaneously constricts afferent arterioles (through prostaglandin inhibition), the net result is a dangerous drop in glomerular filtration pressure. The kidney cannot adequately filter waste. In susceptible patients, this can progress from asymptomatic creatinine elevation to acute kidney injury (AKI) within weeks.
The mechanism behind reduced antihypertensive efficacy is more straightforward: aspirin's anti-inflammatory and antiplatelet effects, combined with its prostaglandin-inhibiting properties, can counteract the vasodilatory benefits of ACE inhibition, making blood pressure control harder to achieve.
Age: The FDA specifically flags elderly patients. People over 65 have naturally declining kidney function, often present with volume depletion from diuretics, and are more prone to acute kidney injury. A 72-year-old on lisinopril for hypertension has substantially higher risk than a 45-year-old.
Existing kidney disease: Patients with baseline chronic kidney disease (CKD) stages 3–5 are at highest risk. If baseline creatinine is already 1.8 mg/dL or eGFR is under 45 mL/min/1.73m², the combination can accelerate kidney decline dangerously.
Volume depletion: Patients on diuretics for heart failure or hypertension, those experiencing diarrhea or vomiting, or individuals in sepsis are volume-depleted. Their kidneys are already struggling to maintain perfusion. Adding aspirin to lisinopril in these patients is particularly risky.
Diabetes: Diabetic patients often have diabetic nephropathy (kidney damage from diabetes). The combination of lisinopril and aspirin in a diabetic with proteinuria requires especially careful monitoring because they have less renal reserve.
Dehydration during summer or exercise: A patient who increases aspirin use during a hot spell or illness, while already on lisinopril, faces acute risk of kidney injury.
Dosage matters: Low-dose aspirin (81 mg daily for cardioprotection) carries lower risk than higher-dose aspirin (500 mg or more for pain relief). A patient taking 325 mg of aspirin twice daily for arthritis faces more risk than one on 81 mg once daily for cardiovascular prevention.
Margaret is a 74-year-old with hypertension and recently diagnosed atrial fibrillation. Her cardiologist prescribed lisinopril 10 mg daily for blood pressure control and aspirin 325 mg daily for stroke prevention. Margaret also takes a thiazide diuretic for resistant hypertension.
Three weeks into this regimen, Margaret feels fatigued and notices mild nausea. Her primary care doctor orders labs. Creatinine has risen from baseline 1.1 mg/dL to 1.4 mg/dL—a 27% increase. Potassium has risen to 5.2 mEq/L (normal is 3.5–5.0). Her eGFR dropped from 52 to 38 mL/min/1.73m²—now CKD stage 3b.
What happened: The combination of lisinopril, aspirin, and diuretic created what clinicians call the "triple whammy"—ACE inhibitor + NSAID/aspirin + diuretic. Margaret's kidneys could not maintain adequate filtration. The lisinopril worked as intended (lowering blood pressure), but aspirin blocked the protective prostaglandin mechanisms, and the diuretic had depleted her intravascular volume.
What should be done: Margaret's aspirin dose should be reduced to 81 mg daily if stroke prevention is still the goal, or substituted with an anticoagulant if her cardiologist deems it necessary for atrial fibrillation. Kidney function should be rechecked in 1–2 weeks. The diuretic may need dose adjustment. Potassium supplementation should be stopped if she's taking it.
James is a 68-year-old who suffered an anterior wall myocardial infarction six months ago. His cardiologist prescribed lisinopril 20 mg daily (for cardiac remodeling prevention and blood pressure control) and aspirin 325 mg daily (to prevent stent thrombosis and recurrent MI). His baseline creatinine was 1.0 mg/dL, eGFR 72, and he was euvolemic (normally hydrated).
Six months into therapy, James develops a urinary tract infection complicated by diarrhea. He continues his aspirin and lisinopril without thinking. Over three days, his diarrhea worsens. By day four, he feels dizzy and weak. He seeks care and labs reveal: creatinine 1.9 mg/dL (nearly doubled), BUN 38 mg/dL (elevated), eGFR 32 mL/min/1.73m² (acute decline to CKD stage 3b). Potassium is 5.4 mEq/L.
What happened: Diarrhea caused acute volume depletion. The combination of lisinopril (which depends on adequate intravascular volume to maintain GFR) and aspirin (which blocked compensatory prostaglandin vasodilation) precipitated acute kidney injury. James's kidneys could not filter adequately, and metabolic waste accumulated rapidly.
What should be done: James should temporarily discontinue aspirin and lisinopril, aggressively rehydrate with IV fluids if necessary, and receive antibiotic treatment for the UTI. Once hydration status improves and kidney function stabilizes (usually within days to weeks), lisinopril can be restarted at a lower dose with close monitoring. Aspirin can be reintroduced at 81 mg daily once kidney function has recovered and remains stable for at least one week.
Before starting the combination: Establish baseline kidney function with serum creatinine and calculated eGFR. Also measure baseline potassium. If eGFR is below 45 mL/min/1.73m², discuss with your doctor whether this combination is necessary or whether alternatives exist.
After starting the combination: Recheck kidney function 1–2 weeks after initiating lisinopril, and again 2–4 weeks later. A creatinine increase of more than 30% or eGFR decline of more than 25% warrants urgent discussion with your doctor. An expected small rise in creatinine (up to 20%) can occur as lisinopril stabilizes kidney hemodynamics, but beyond that signals a problem.
If you must take both: Keep aspirin dose as low as clinically effective—81 mg daily is preferable to 325 mg if your indication allows. Avoid additional NSAIDs (ibuprofen, naproxen), as they compound the risk. Stay well-hydrated. Report any new symptoms of kidney problems: decreased urination, fatigue, swelling in legs or face, or shortness of breath.
Dosage adjustments: If kidney function declines, lisinopril may need dose reduction or discontinuation. Aspirin dose may also need reduction. Your doctor can guide this based on your kidney numbers and clinical status.
Alternative strategies: For patients requiring both cardiovascular and renal protection, some cardiologists substitute acetaminophen for aspirin when feasible for pain management, or use selective COX-2 inhibitors (like celecoxib, which has relatively less impact on renal prostaglandins compared to nonselective NSAIDs, though not risk-free). Some patients may switch to other antihypertensives like beta-blockers or calcium-channel blockers if ACE inhibitor + aspirin proves problematic.
Seek urgent medical attention if you experience:
FDA Drug Labeling:
Clinical Literature:
Pharmacological Databases:
Lisinopril and aspirin are just one potential interaction. If you're taking multiple medications—especially blood pressure drugs, pain relievers, anti-inflammatories, diuretics, or supplements—your risk profile is more complex. Visit checkdruginteractions.com to enter your complete medication list and receive a comprehensive safety analysis powered by FDA drug labels and the NIH National Library of Medicine. Our interaction checker has analyzed over 250,000 FDA labels to help you identify major, moderate, and minor interactions you should discuss with your pharmacist or doctor. Do not delay—drug interactions can change suddenly, and your pharmacist may catch something your doctor missed. Check your medications today.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.